Angiotensin converting enzyme inhibitors remain the first treatment of choice
The Korean Journal of Internal Medicine
; : 237-241, 2016.
Article
在 En
| WPRIM
| ID: wpr-36008
Responsible library:
WPRO
ABSTRACT
No abstract available.